SCHEMBL22983336

SCHEMBL22983336

C[C@]1(CO)CN(Cc2ccccc2)C[C@@H]1c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.49
RORC P51449 1/20 0.49
SIGMAR1 Q99720 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
KDM1A O60341 2/20 0.42
RCOR1 Q9UKL0 2/20 0.42
CCR3 P51677 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ITGB2 P05107 1/20 0.42
ICAM1 P05362 1/20 0.42
ITGAL P20701 1/20 0.42
TSHR P16473 1/20 0.41
GAA P10253 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL321358 1.00 NR1I2 (0.49) NR1I2RORCSIGMAR1MEN1KMT2A
SCHEMBL10026136 1.00 NR1I2 (0.49) NR1I2RORCSIGMAR1MEN1KMT2A
SCHEMBL10277293 0.81 NR1I2 (0.48) NR1I2RORCSIGMAR1CHRM2CHRM3
SCHEMBL10277297 0.81 NR1I2 (0.48) NR1I2RORCSIGMAR1CHRM2CHRM3
SCHEMBL6837076 0.79 TACR3 (0.59)
SCHEMBL22983166 0.79 TACR3 (0.59)
SCHEMBL1393924 0.79 TACR3 (0.59)
SCHEMBL10277142 0.78 NR1I2 (0.46) NR1I2RORCSIGMAR1DRD2DRD4
SCHEMBL24245573 0.78 OPRM1 (0.48) NR1I2RORCSIGMAR1MEN1KMT2A
SCHEMBL19779539 0.78 OPRM1 (0.48) NR1I2RORCSIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030335-A1 A STEREOISOMERICALLY PURE NK-3 RECEPTOR ANTAGONIST AND CRYSTALLINE FORMS THEREOF MILLENDO THERAPEUTICS, INC. (US) 2021-02-18 WO disclosed
WO-2021030335-A1 A STEREOISOMERICALLY PURE NK-3 RECEPTOR ANTAGONIST AND CRYSTALLINE FORMS THEREOF MILLENDO THERAPEUTICS, INC. (US) 2021-02-18 WO disclosed